Project Grant R43CA291627

Award Date 6/1/24
Completion Date 5/31/25
Dollars Obligated $400K
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92121, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant awarded $274,440 to Vine Medical Inc., a for-profit manufacturing company, to develop a proof-of-concept for a self-deploying endotracheal intubation device. The proposed soft robotics system aims to achieve over a 90% first-pass intubation success rate, which would improve patient outcomes and reduce complications during emergency airway management procedures. The device is designed to...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is funding the development of a nanofiber patch for the treatment of pediatric tracheal stenosis, a life-threatening condition involving airway narrowing. The $154,000 award to Colorado State University aims to create a synthetic trachea patch that can maintain airway patency and regenerate cartilage-like...
Teliatry Inc. received a $768,138 project grant award from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering to develop a minimally invasive, single incision, rechargeable spinal cord stimulation system for chronic pain management. The grant was awarded under the Discovery and Applied Research for Technological Innovations to Improve Human Health program. Through this award, Teliatry will engineer the world's smallest (0.75cc), most cost-effective...
The National Science Foundation awarded a $256,000 Small Business Technology Transfer Phase I Project Grant to develop a minimally invasive articulating intubation stylet. The grant period runs from June 15, 2021 through May 31, 2022 under the Engineering (47.041) program. This program aims to foster innovation and excellence in engineering research and education across various fields. Funds will support the awardee, located in Blaine, Minnesota, to research and develop a new medical device...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $571,410 to Pharynvac Surgical Technology Inc. to develop a novel device called the PharynVac for reducing aerosolized particles during endonasal (sinus) surgeries. The PharynVac is a balloon aspiration catheter designed to simultaneously address three key...
This $608,826 Project Grant awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) will develop a new class of wireless, skin-conformable, and dual-sensing wearable system to monitor voice and upper airway (VUA) health. The key products and services to be delivered include: A single neck-worn wearable device that uses neck surface accelerometry and surface electromyography to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), supports the continued clinical development of a novel pleural and tracheal sealant. The $381,000 award to the University of Vermont will fund research to: 1) define optimal manufacturing, sterilization, and storage conditions for the sealant patch; 2) further evaluate the long-term safety and efficacy of the sealant in animal models...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) project grant of $274,999 awarded to Materialize Bio, Inc. in Somerville, MA aims to develop a novel manufacturing approach for biopolymer-based implantable medical devices, specifically next-generation tympanostomy tubes. The project focuses on a groundbreaking method to 3D print molds, use centrifugation and polymerization to create complex biopolymer structures, and produce degradable, biocompatible,...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop a cost-effective Optical Sensor-Enabled Endotracheal Tube (OS-ETT) to reduce the risks of esophageal intubation and unintended extubation. The $1,013,000 award, effective September 1, 2024 through August 31, 2025, will support the feasibility demonstration of the OS-ETT, including optimizing the LED-photodiode array and signal processing algorithm for vocal...
This $256,000 National Science Foundation project grant supports the development of an automated chest tube to prevent clotting. Circulatech LLC will design and prototype a novel chest tube that proactively manages fluid flow within the catheter lumen to flush and drain the tube, reducing blood clot formation. Through a process called "dilutional coagulopathy," the tube will use sterile saline or anticoagulants to reduce thrombosis in the drainage space rather than relying on...

NOVEL TRACHEOSTOMA DEVICE - ABSTRACT SURGICAL REMOVAL OF THE LARYNX PROFOUNDLY AFFECTS A PATIENT'S QUALITY OF LIFE, PARTICULARLY IN THE LOSS OF NORMAL VOCALIZATION, PHYSICAL CHANGE IN APPEARANCE, AND EMOTIONAL CHALLENGES TO ADAPT TO LIVING A NORMAL LIFE. POST OPERATIVELY, A LARYNGECTOMY REQUIRES A PATIENT'S STOMA TO BE PROTECTED UTILIZING VARIOUS HEAT MOISTER EXCHANGE (HME) FILTERS, WHICH ATTACH WITH DEVICES EITHER (I) EXTRALUMINAL USING ADHESIVES AND STRAPS AROUND THE STOMA OR (II) INTRALUMINAL USING A TRACHEOSTOMAL BUTTON ("TE BUTTON") INSERTED INTO THE STOMA. UTILIZATION OF EITHER DEVICE IS CHALLENGING FOR THE PATIENT, EXTRALUMINAL ADHESIVE-BASED DEVICES REQUIRE CHANGE SEVERAL TIMES PER WEEK, CAUSING TISSUE IRRITATION AND INJURY, SOCIAL AND EMOTIONAL STRESS, FRUSTRATION, AND DEVICE FAILURE. THE EXISTING PRODUCTS FOR LARYNGECTOMY PATIENTS HAVE BEEN VOID OF MEANINGFUL INNOVATION FOR OVER 20 YEARS, UTILIZING ANTIQUATED MATERIALS WHILE IGNORING THE VAST NUMBER OF INNOVATIONS IN BIOCOMPATIBLE MATERIALS AND TECHNOLOGY THAT COULD ADDRESS MOST PATIENT ISSUES. TE BUTTON FAILURE IS EASILY IDENTIFIABLE AND THE BYPRODUCT OF TE BUTTONS' CIRCULAR AND RIGID DESIGN WHICH UNEVENLY DISPLACES PRESSURE DUE TO LACK OF UNIFORMITY UNIQUE TO EACH LARYNGECTOMY REGARDING TRACHEOSTOMAL ANATOMY. THIS RESULTS IN POOR TOLERABILITY AND RETENTION DUE TO DERMAL IRRITATION, TISSUE EROSION, AND RANDOM DISLODGING FROM THE STOMA CAUSED BY THE DEVICE'S MOVEMENT WITHIN THE TRACHEAL LUMEN DURING NORMAL DAILY ACTIVITIES, SPEECH, AND RESPIRATION. MOST LARYNGECTOMY PATIENTS HAVE UNDERGONE MONTHS OR YEARS OF TRAUMATIC SURGERIES, CHEMOTHERAPY, AND RADIATION THEN ATTEMPT TO REENTER SOCIETY WITH SIGNIFICANT CHANGES IN PHYSICAL APPEARANCE, SOCIAL ANXIETIES, EMOTIONAL STRESS, AND FRUSTRATION AS THEY ADAPT TO THEIR 'NEW' NORMAL QUALITY OF LIFE. TE BUTTON FAILURES LIMIT A PATIENT'S ABILITY TO SUCCESSFULLY UTILIZE VARIOUS INTRALUMINAL ATTACHMENTS SUCH AS A TRACHEOESOPHAGEAL (TE) VOICE RESTORATION DEVICES FOR HANDS-FREE TE SPEECH PRODUCTION. THESE TE BUTTON FAILURES REDUCE QUALITY OF LIFE, IMPEDING THE ABILITY TO RETURN TO NORMAL DAILY ROUTINES AND ACTIVITIES AFTER TOTAL REMOVAL OF THEIR LARYNX. THIS PHASE I PROPOSAL AIMS TO DEVELOP A TE BUTTON CAPABLE OF IMPROVED STABILITY, DURABILITY, REDUCED PISTONING AND RELATIVE MOTION BECAUSE IT ADAPTS TO VARIOUS STOMAL GEOMETRIES AND CONFIGURATIONS. THIS PROJECT WILL PROVIDE AN ALTERNATIVE FOR HANDS-FREE SPEECH PRODUCTION TO PATIENTS WHO ARE UNABLE TO USE CURRENTLY AVAILABLE INTRALUMINAL DEVICES. WE AIM TO UTILIZE THE ADVANCES IN MATERIAL SCIENCES THAT HAVE OCCURRED SINCE THE ORIGINAL TRACHEOSTOMA BUTTONS WERE INVENTED. THESE INCLUDE HIGH ELONGATION, HIGH TEAR STRENGTH, LOW DUROMETER SILICONE ELASTOMERS AND THE LOWER COST OF NITINOL WIRE AND COMPOSITES OF WIRE SUCH AS BRAIDS AND STENTS.

Posted 6/27/24, 12:00 AM